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Capsaicin, the pungent extract of red peppers, has been used in clinical research for almost three decades.
Capsaicin has gained favor as the provocative agent of choice to measure cough reflex sensitivity, as it induces
cough in a safe, reproducible, and dose-dependent manner. One of the major uses of capsaicin cough challenge
testing has been to evaluate the effect of a pharmacological intervention on the human cough reflex. The current
review summarizes the published experience with capsaicin inhalation challenge in the evaluation of drug effects
on cough reflex sensitivity. A notable contrast evident between studies demonstrating a drug effect (inhibition of
cough reflex sensitivity) and those that do not, is the predominance of healthy volunteers as subjects in the latter.
This observation suggests that subjects with pathological cough, rather than normal volunteers, comprise the
optimal group in which to evaluate the effect of potential antitussive agents on human cough reflex sensitivity.
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Capsaicin, the pungent extract of red pepper (capsicum),
has gained widespread use as a research tool among
clinical investigators, as it induces cough in humans in a
safe [1], dose-dependent, and reproducible manner [2,3].
Capsaicin cough challenge in humans was first described
in 1984 [4], and has since been used to evaluate the effect
of numerous pharmacological agents on cough reflex
sensitivity. Although many drugs have been shown to
inhibit induced cough in the laboratory, others have
failed to do so, including agents widely regarded as
clinically effective antitussives.
Methods
A United States National Library of Medicine (PubMed)
search was performed in September, 2012 using the
search terms “cough” and “capsaicin” limited to human
studies published in English. The abstracts of the 328
articles meeting those search criteria were reviewed and
56 studies were identified in which capsaicin cough chal-
lenge was employed to assess the effect of a pharmaco-
logical intervention on cough reflex sensitivity. StudiesCorrespondence: pdicpin@gmail.com
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reproduction in any medium, provided the orin which a positive drug effect was demonstrated (n = 33)
are listed in Table 1 [5-37]; trials in which no effect was
noted (n = 30) are summarized in Table 2 [4,10,12,17-
19,35,37-59]. In seven of these studies, multiple drugs
and/or multiple subject groups were evaluated, resulting
in both positive and negative results in terms of assess-
ment of drug activity. As the purpose of this review
was to assess drug trials in which a potential therapeutic
(antitussive) effect of a drug was being evaluated, studies
demonstrating enhancement of cough reflex sensitivity by
angiotensin-converting enzyme (ACE) inhibitors or other
agents were excluded.Discussion
This review has identified 33 studies in which a pharma-
cological intervention was demonstrated to inhibit
cough reflex sensitivity to inhaled capsaicin in a variety
of subject populations, thus supporting the role of cough
challenge as a useful clinical tool in the evaluation of
potential antitussives [3]. A striking difference between
the studies showing a positive drug effect (Table 1), and
those failing to demonstrate a change in cough reflex
sensitivity (Table 2) is the predominant subject popula-
tions studied. Of the negative studies, 70% involved
evaluation of healthy volunteers. Among the trials dis-
playing a positive drug effect, only 27% evaluated healthyLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Drugs shown to inhibit cough reflex sensitivity to capsaicin
1st author Ref. # Year Drug Subject population
Wise P [5] 2012 menthol healthy volunteers
Takemura M [6] 2012 montelukast cough-variant asthma
Ekstrand Y [7] 2011 inhaled steroids asthma
Ishiura Y [8] 2010 etodolac sinobronchial syndrome
Ishiura Y [9] 2009 etodolac asthma
Dicpinigaitis P [10] 2009 guaifenesin viral URI
Davenport P [11] 2009 nicotine healthy smokers
Dicpinigaitis P [12] 2008 tiotropium viral URI
Ishiura Y [13] 2008 suplatast atopic cough
Ferrari M [14] 2007 omeprazole asthma + GERD
Usmani O [15] 2005 theobromine healthy volunteers
Shioya T [16] 2004 epinastine atopic cough
Dicpinigaitis P [17] 2003 guaifenesin viral URI
Ishiura Y [18] 2003 carbocysteine asthma
Ishiura Y [19] 2003 seratrodast chronic bronchitis
Shioya T [20] 2002 suplatast cough-variant asthma
Dicpinigaitis P [21] 2002 zafirlukast cough-variant asthma
Ceyhan B [22] 2002 oxolamine COPD
Dicpinigaitis P [23] 2000 baclofen cervical SCI
Brightling C [24] 2000 budesonide eosinophilic bronchitis
Dicpinigaitis P [25] 1998 baclofen healthy volunteers
Shioya T [26] 1998 azelastine asthma
Dicpinigaitis P [27] 1997 baclofen healthy volunteers
Shioya T [28] 1996 azelastine cough-variant asthma
Fujimura M [29] 1995 indomethacin asthma, chronic bronchitis
Hargreaves M [30] 1995 sodium cromoglycate ACE-inhibitor cough
Hansson L [31] 1994 lignocaine healthy volunteers
Van Wyck M [32] 1994 glycopyrrolate ACE-inhibitor cough
Cazzola M [33] 1993 theophylline ACE-inhibitor cough
Foster G [34] 1991 sulindac healthy volunteers
McEwan J [35] 1990 sulindac ACE-inhibitor cough
Choudry N [36] 1990 lignocaine healthy volunteers
Fuller R [37] 1988 codeine,morphine healthy volunteers
Abbreviations: URI-acute upper respiratory tract infection; GERD-gastroesophageal reflux disease; SCI-spinal cord injury; ACE-angiotensin-converting enzyme.
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forms of pathological cough. Of note, multiple agents
were shown to inhibit cough reflex sensitivity in patho-
logical cough, while having no effect in healthy volun-
teers, including guaifenesin [10,17] and tiotropium [12]
in cough due to acute viral upper respiratory tract in-
fection (URI; common cold). The leukotriene receptor
antagonist zafirlukast inhibited capsaicin-induced cough
in subjects with cough-variant asthma [21], but not in
stable asthmatics without cough and healthy volunteers
[44]. Interestingly, gabapentin has recently been shown
to improve cough-specific quality of life in patients with
refractory chronic cough, without affecting cough reflexsensitivity [38]. This particular study highlights the con-
cept that the optimal approach to the evaluation of a
potential antitussive agent should be multifaceted, with
cough reflex sensitivity measurement complementing
other measures, such as objective cough counting and
subjective symptom-based questionnaires.
Conspicuous in their absence from the list of agents
having demonstrated the ability to inhibit cough reflex
sensitivity to capsaicin during URI are codeine and dex-
tromethorphan, two of the most commonly used agents
worldwide for the treatment of cough due to the com-
mon cold [60]. The only agents demonstrating the ability
to inhibit cough reflex sensitivity to capsaicin in healthy
Table 2 Drugs shown not to inhibit cough reflex sensitivity to capsaicin
1st author Ref. # Year Drug Subject population
Ryan M [38] 2012 gabapentin chronic cough
Yousaf N [39] 2010 erythromycin chronic cough
Dicpinigaitis P [10] 2009 benzonatate viral URI
Dicpinigaitis P [12] 2008 tiotropium healthy volunteers
Davenport P [40] 2007 codeine healthy volunteers
Dicpinigaitis P [41] 2003 fexofenadine healthy volunteers
Dicpinigaitis P [17] 2003 guaifenesin healthy volunteers
Ishiura Y [18] 2003 ambroxol asthma
Ishiura Y [19] 2003 pranlukast chronic bronchitis
Dicpinigaitis P [42] 2001 celecoxib asthma
Fujimura M [43] 2000 mexiletine healthy volunteers
Dicpinigaitis P [44] 1999 zafirlukast asthma without cough
Capon D [45] 1996 dextromethorphan healthy volunteers
Hansson L [46] 1994 nicotine healthy nonsmokers
Hutchings H [47] 1994 codeine healthy volunteers
O’Connell F [48] 1994 clonidine healthy volunteers
Fujimura M [49] 1993 procaterol asthma, chronic bronchitis
Choudry N [50] 1993 MAO inhibitors healthy volunteers
Stone R [51] 1993 5-HT (serotonin) healthy volunteers
Fujimura M [52] 1992 procaterol healthy volunteers
Ventresca P [53] 1992 furosemide healthy volunteers
Karlsson J [54] 1992 furosemide, HCTZ healthy volunteers
Studham J [55] 1992 terfenadine healthy volunteers
Choudry N [56] 1991 inhaled mu opioid agonist healthy volunteers
Smith C [57] 1991 salbutamol, ipratropium healthy volunteers
Choudry N [58] 1991 granisteron (5-HT3) healthy volunteers
McEwan J [35] 1990 sulindac idiopathic cough
Hansson L [59] 1988 nedocromil healthy volunteers
Fuller R [37] 1988 inhaled opiates healthy volunteers
Collier J [4] 1984 sodium cromoglycate healthy volunteers
Abbreviations: URI-acute upper respiratory tract infection; MAO-monoamine oxidase; HCTZ-hydrochlorothiazide.
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inhaled lignocaine [31,36], sulindac [34], systemic opi-
ates [37], menthol [5] and, in healthy smokers, nicotine
[11]. Interestingly, this list includes drugs thought to be
centrally acting antitussives, as well as agents whose
cough-inhibiting properties are presumed to occur
through a peripheral mechanism.
Limiting the evaluation of a potential modulator of
cough reflex sensitivity to a study group of healthy
volunteers, whose cough reflex is not hyperresponsive,
may not allow the drug to demonstrate its inhibitory
effect. Thus, subjects with pathological cough appear to
comprise the optimal study population when evaluating
the effects of a potential antitussive agent on cough reflex
sensitivity. The particular type of pathological cough best
suited for evaluation of a novel antitussive may dependon the specific pharmacological action of the drug, and
currently remains a question under vigorous debate.
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